Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Mendel Gene Technology is a biotechnology company specializing in precision medicine and clinical genetic testing services. Based in Nanjing, China, the company leverages high-throughput sequencing and bioinformatics to provide diagnostic solutions for oncology, reproductive health, and rare genetic disorders. Their core offerings include non-invasive prenatal testing (NIPT) and hereditary cancer screening panels designed to assist in early disease detection and personalized treatment planning. The company operates a state-of-the-art laboratory infrastructure to support clinical partners and research institutions. By integrating genomic data into routine clinical practice, they aim to improve patient outcomes through targeted diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Mendel Gene Technology.